OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC

Andrea Bezjak,Rebecca Paulus,Laurie E. Gaspar,Robert D. Timmerman,William L. Straube, W. Ryan,Yolanda I. Garces,A.T. Pu,A.K. Singh,G.M.M. Videtic,Ronald C. McGarry,Puneeth Iyengar,J.R. Pantarotto,James J. Urbanic,A.Y. Sun,Megan E. Daly,I.S. Grills,D.P. Normolle,Jeffrey D. Bradley,Hak Choy

RADIOTHERAPY AND ONCOLOGY（2016）

引用 5|浏览27

暂无评分

摘要

S61 ______________________________________________________________________________________________________properties are dynamic in nature.Therapeutic agents inhibiting tumor cell reprogramming may have the potential to increase the effectiveness of radiotherapy.Moreover, monitoring of CSC-related biomarker before and during the course of radiotherapy may be able to predict therapy response and clinical outcome.

查看译文

关键词

Tumor Staging,Radiotherapy,Radiotherapy Physics,Cancer Imaging,CT Screening

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要